Ajay Madan, Chief Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 26,822 shares at $17.83 ($478K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Open-market sale of $478k CRNX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.83 | 13,411 | $239K | 50.0% |
| 2 | $17.83 | 13,411 | $239K | 50.0% |
| Total | $17.83 avg | 26,822 | $478K | 100% |